You are here

Article Text

Article menu
Download PDFPDF
Editorial
Glaucoma: a systemic condition?
  1. Leopold Schmetterer1,2
  1. 1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
  2. 2Center of Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  1. Correspondence to Professor Leopold Schmetterer, Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; leopold.schmetterer{at}meduniwien.ac.at

https://doi.org/10.1136/bjophthalmol-2012-301615

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Primary open-angle glaucoma (POAG) is an optic neuropathy associated with the loss of retinal ganglion cells. The pathophysiology of the disease is incompletely understood. Increased intraocular pressure (IOP) is the most important risk factor for the disease, although many individuals with elevated IOP never develop glaucoma, and glaucomatous damage can occur despite IOP levels in the normal range. Several large-scale trials have proved that the progression of visual field loss can be retarded by reducing …

    View Full Text

    Footnotes

    • Linked article 300945.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles